Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 1;20:75. doi: 10.1186/s12882-019-1243-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 8 — GLP-1R in cardiac progenitor cells and myocardium by ischemia. A Western blot of cardiac progenitor cells with hypoxic injury. B GLP-1R Immunoreactivity of myocardium. a and e, control; b and f, MI/R 1 day; c and g, MI/R 1 days; d and h, MI/R 7 days; i and l, MI/R 1 day with linagliptin-treated; j and m, MI/R 3 day with linagliptin-treated; k and n, MI/R 7 day with linagliptin-treated group. C Masson’s Trichrome staning of myocardium. a, control; b, MI/R 1 day; c, MI/R 1 day with linagliptin-treated; d, MI/R 3 days; e, MI/R 3 day with linagliptin-treated; f, MI/R 7 day; g, MI/R 7 day with linagliptin-treated group. MI/R, myocardial ischemia/reperfusion; Lina, linagliptin. A a-d and i-k, magnification 200×; e-h and l-m, magnification 400×. C a-g, magnification 40 ×